Does UPADACITINIB Cause Oedema peripheral? 150 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 150 reports of Oedema peripheral have been filed in association with UPADACITINIB (Rinvoq). This represents 0.2% of all adverse event reports for UPADACITINIB.
150
Reports of Oedema peripheral with UPADACITINIB
0.2%
of all UPADACITINIB reports
18
Deaths
61
Hospitalizations
How Dangerous Is Oedema peripheral From UPADACITINIB?
Of the 150 reports, 18 (12.0%) resulted in death, 61 (40.7%) required hospitalization, and 19 (12.7%) were considered life-threatening.
Is Oedema peripheral Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 150 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Oedema peripheral?
AMBRISENTAN (2,959)
TREPROSTINIL (2,816)
ADALIMUMAB (2,356)
LENALIDOMIDE (2,298)
AMLODIPINE (2,076)
PREDNISONE (2,029)
METHOTREXATE (1,939)
MACITENTAN (1,932)
RITUXIMAB (1,698)
TOCILIZUMAB (1,574)
Which UPADACITINIB Alternatives Have Lower Oedema peripheral Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL